Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
The Policy Layer: How Legislative and Regulatory Changes Shift the Sourcing Environment Patent expiry timelines and supply chain geography do not exist in a policy vacuum
Tc dng ph Mt s ngi c th gp bun nn, tiu chy, hoc d ng nh
Nutrients, 14 (14), 2831
Randomized clinical trial comparing the efficacy and safety of treatment with the once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor omarigliptin or the once-daily DPP-4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy
US$ 27.12
US$ 24.55
US$ 20.91
US$ 21.97
US$ 27.91
US$ 29.75
US$ 22.95
US$ 22.64
